These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 40393)

  • 1. Naloxone: a potent ketobemidone antagonist in man.
    Holst-Larsen H; Aasen AO; Rugstad HE
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):91-5. PubMed ID: 40393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone reversal of ketobemidone induced respiratory, circulatory and narcotic effects in dogs.
    Aasen AO; Holst-Larsen H; Ormstad K; Rugstad HE
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():118-28. PubMed ID: 19923
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of naloxone to reverse carfentanil citrate-induced hypoxemia and cardiopulmonary depression in Rocky Mountain wapiti (Cervus elaphus nelsoni).
    Moresco A; Larsen RS; Sleeman JM; Wild MA; Gaynor JS
    J Zoo Wildl Med; 2001 Mar; 32(1):81-9. PubMed ID: 12790400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Minidose naloxone reverses respiratory depression, but not analgesia, at the end of narcotic-supplemented anesthesia].
    Pizov R; Shir Y; Perel A
    Harefuah; 1987 Jan; 112(2):68-70. PubMed ID: 2885248
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged apnea after remifentanil.
    Nelson RY; Bretz B; Egan TD
    J Clin Anesth; 2007 Feb; 19(1):60-3. PubMed ID: 17321930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of remifentanil for inducing apnea during diagnostic imaging in sedated pediatric patients.
    Jöhr M; Berger TM; Burki S; Schmid E
    Paediatr Anaesth; 2008 Dec; 18(12):1221-2. PubMed ID: 18673312
    [No Abstract]   [Full Text] [Related]  

  • 9. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone-resistant respiratory depression and neurological eye symptoms after intrathecal morphine.
    Krenn H; Jellinek H; Haumer H; Oczenski W; Fitzgerald R
    Anesth Analg; 2000 Aug; 91(2):432-3. PubMed ID: 10910863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
    Crain SM; Shen KF
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased antagonist potency of naloxone caused by morphine pretreatment in mice.
    Wong CL; Bentley CA
    Eur J Pharmacol; 1978 Feb; 47(4):415-22. PubMed ID: 564774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys.
    Gatch MB; Liguori A; Negus SS; Mello NK; Bergman J
    Eur J Pharmacol; 1996 Feb; 298(1):31-6. PubMed ID: 8867916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil.
    Amin HM; Sopchak AM; Esposito BF; Henson LG; Batenhorst RL; Fox AW; Camporesi EM
    J Pharmacol Exp Ther; 1995 Jul; 274(1):34-9. PubMed ID: 7616418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T; Miller JH; Irvine RJ
    Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic effects of naloxone and naloxonazine on sufentanil-induced antinociception and respiratory depression in rats.
    Verborgh C; Meert TF
    Pain; 1999 Oct; 83(1):17-24. PubMed ID: 10506668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented breaths ('sighs') are suppressed by morphine in a dose-dependent fashion via naloxone-sensitive pathways in adult rats.
    Bell HJ; Pankuch G
    Respir Physiol Neurobiol; 2013 Jan; 185(2):296-303. PubMed ID: 23043875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2004 May; 151(1-2):151-8. PubMed ID: 15084430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose naloxone in the treatment of urinary retention during extradural fentanyl causes excessive reversal of analgesia.
    Wang J; Pennefather S; Russell G
    Br J Anaesth; 1998 Apr; 80(4):565-6. PubMed ID: 9640172
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of alfentanil and fentanyl in short operations with special reference to their duration of action and postoperative respiratory depression.
    van Leeuwen L; Deen L; Helmers JH
    Anaesthesist; 1981 Aug; 30(8):397-9. PubMed ID: 6116461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.